Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025
Fulgent Genetics (NASDAQ: FLGT) has announced it will release its fourth quarter and full year 2024 financial results before market opens on Friday, February 28, 2025. The company will host a conference call for investors at 8:30 AM ET (5:30 AM PT) on the same day, where management will discuss results and answer questions. The call will be accessible through a live audio webcast on the Investor Relations section of Fulgent's website, with an audio replay available afterward.
Fulgent Genetics (NASDAQ: FLGT) ha annunciato che pubblicherà i propri risultati finanziari del quarto trimestre e dell'intero anno 2024 prima dell'apertura del mercato venerdì 28 febbraio 2025. L'azienda ospiterà una conferenza telefonica per gli investitori alle 8:30 AM ET (5:30 AM PT) nello stesso giorno, durante la quale la direzione discuterà i risultati e risponderà alle domande. La chiamata sarà accessibile tramite un webcast audio dal vivo nella sezione Relazioni con gli Investitori del sito web di Fulgent, con una registrazione audio disponibile in seguito.
Fulgent Genetics (NASDAQ: FLGT) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 antes de la apertura del mercado el viernes 28 de febrero de 2025. La empresa llevará a cabo una conferencia telefónica para inversionistas a las 8:30 AM ET (5:30 AM PT) el mismo día, donde la dirección discutirá los resultados y responderá preguntas. La llamada será accesible a través de un webcast de audio en vivo en la sección de Relaciones con Inversionistas del sitio web de Fulgent, con una repetición de audio disponible posteriormente.
풀젠트 유전자 (NASDAQ: FLGT)는 2024년 4분기 및 연간 재무 결과를 2025년 2월 28일 금요일 시장 개장 전 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8:30 ET (오전 5:30 PT)에 투자자를 위한 컨퍼런스 콜을 개최하며, 경영진은 결과에 대해 논의하고 질문에 답변할 것입니다. 이 전화는 풀젠트 웹사이트의 투자자 관계 섹션을 통한 실시간 오디오 웹캐스트를 통해 접근할 수 있으며, 이후에 오디오 재생이 가능합니다.
Fulgent Genetics (NASDAQ: FLGT) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année 2024 avant l'ouverture du marché le vendredi 28 février 2025. La société organisera une conférence téléphonique pour les investisseurs à 8h30 ET (5h30 PT) le même jour, où la direction discutera des résultats et répondra aux questions. L'appel sera accessible via un webinaire audio en direct dans la section Relations Investisseurs du site Web de Fulgent, avec un enregistrement audio disponible par la suite.
Fulgent Genetics (NASDAQ: FLGT) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 vor Börseneröffnung am Freitag, den 28. Februar 2025, veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:30 Uhr ET (5:30 Uhr PT) eine Telefonkonferenz für Investoren abhalten, in der die Geschäftsführung die Ergebnisse besprechen und Fragen beantworten wird. Die Konferenz ist über einen Live-Audio-Webcast im Bereich Investor Relations auf der Website von Fulgent zugänglich, und eine Audio-Widerholung wird anschließend verfügbar sein.
- None.
- None.
The call may be accessed through a live audio webcast on the Investor Relations section of the Company’s website, http://ir.fulgentgenetics.com. An audio replay will be available at the same location.
About Fulgent
Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business. Fulgent’s laboratory services business, which was formerly referred to as the clinical diagnostic business, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Fulgent’s therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The Company aims to transform from a genomic diagnostic business into a fully integrated precision medicine company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250206889915/en/
Investor Relations Contact:
The Blueshirt Group
Melanie Solomon, melanie@blueshirtgroup.com
Source: Fulgent Genetics, Inc.
FAQ
When will Fulgent Genetics (FLGT) release Q4 and full year 2024 earnings?
What time is FLGT's Q4 2024 earnings conference call?
How can investors access FLGT's Q4 2024 earnings call?
Will there be a replay available for FLGT's Q4 2024 earnings call?
